Structure of PEG Loxenatide Tirzepatide Tirzepatide is a dual GIP/GLP-1 receptor agonist that activates both the GLP-1 and GIP signaling pathways
Ongoing Support We will schedule regular check-ins and monitoring of your progress to ensure the effectiveness of the treatment and make any necessary adjustments
Correlating quantitative metrics with clinical and patient-reported metrics will be essential to understanding the true adverse effects of GLP-1 RA use if any
If you are taking individual injections, ask staff to cap the end of the plunger so it is not accidently dislodged ejecting the medication
Whilst these medications effectively reduce appetite and support weight loss, they can inadvertently lead to insufficient protein intake
Common side effects may include: Nausea: Especially after meals or following a dose increase Vomiting: Triggered by persistent or severe nausea Constipation: Due to slower digestion and reduced food intake Diarrhea: Including loose stools or changes in bowel habits Bloating: Caused by delayed stomach emptying Abdominal discomfort: Such as mild cramping, pressure, or digestive upset Tips to manage GLP-1 side effects Reduce portion sizes Many patients find that eating smaller meals helps reduce nausea and digestive discomfort